High-risk localized prostate cancer treated with neoadjuvant LHRH agonist/antagonist and enzalutamide plus the glucocorticoid receptor antagonist relacorilant versus placebo. This is an ASCO Meeting ...
A randomized trial conducted by the Alliance for Clinical Trials in Oncology with support from the National Cancer Institute has found that duloxetine, a medication commonly used to treat chronic pain ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
University of Cincinnati researchers found extended-release buprenorphine helped pregnant women avoid illegal opioids better ...
In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage ...
Envudeucitinib, another allosteric TYK2 inhibitor, also achieved PASI 75 in 70-75% of patients at 16 weeks and PGA 0/1 status ...
SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT ...
Morning Overview on MSN
Study finds AI health chatbots do not improve self-diagnosis
A randomized trial led by researchers at the University of Oxford found that people who used AI chatbots to assess their ...
Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results